Clinical trial · Interventional
Pilot Breast-Dedicated PET Camera With 1 Millimeter Spatial Resolution
Pilot Study of a Breast-Dedicated PET Camera With 1 Millimeter Spatial Resolution
NCT04016818CI-TRIAL-00112908withdrawnEarly Phase 1ClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Why stopped (as posted): Awaiting more funding to build a more stable technology.
Summary
Brief summary (as posted)
This is a research study of a novel, "breast-dedicated" positron emission tomography (PET) camera with 1 millimeter spatial resolution. The main goal of the study is for the personnel to understand practical and logistical issues with using the camera in the clinic
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Breast Cancer | Malignant Breast Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| 18F-FDG | Drug | — | UNRESOLVED |
| Breast-dedicated PET camera | Device | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- 18-F FDG Study using Breast-Dedicated PET Camera
- description
- Breast-Dedicated PET Camera will be used with standard PET 18-F FDG tracer dose
- interventionNames
- Drug: 18F-FDG
- Device: Breast-dedicated PET camera
Primary outcomes (1)
- measure
- Image quality with the breast-dedicated PET camera
- timeFrame
- 1 day
- description
- Feasibility of the pilot breast-dedicated PET camera will be assessed on the basis of whether acceptable images are obtained. Images will be assessed and graded as 1 of 3 quality ratings: excellent, good, and poor. The outcome will be reported as the number of images that are excellent, good, and poor, a number without dispersion.
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Biopsy-confirmed breast cancer measuring ≥ 5 mm on mammogram or ultrasound. * Prior diagnostic imaging test(s) with another modality such as MRI, CT, or x-ray mammography (or other applicable imaging modalities) within 60 days prior to the study date. * Documented written informed consent document. Exclusion Criteria: * 1\. Additional condition, or extenuating circumstance that, in the opinion of the investigator, may interfere with study compliance. * Known allergies to FDG * Pregnant or nursing.
References
Publications (0)
Data not yet available
No reference posted for this study.